GT Biopharma (GTBP)
(Real Time Quote from BATS)
$2.00 USD
-0.05 (-2.44%)
Updated Sep 23, 2024 03:06 PM ET
After-Market: $2.00 0.00 (0.00%) 4:06 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
GTBP 2.00 -0.05(-2.44%)
Will GTBP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GTBP based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GTBP
GT Biopharma, Inc. (GTBP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Here's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock Now
GTBP: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About GT Biopharma, Inc. (GTBP) Rating Upgrade to Buy
Has Albireo Pharma (ALBO) Outpaced Other Medical Stocks This Year?
Other News for GTBP
GT Biopharma’s Dr. Miller Assumes New Medical Director Role
GT Biopharma GAAP EPS of -$2.17
GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GTBP Stock Earnings: GT Biopharma Reported Results for Q2 2024
One new option listing and eighteen option delistings on July 22nd